rare-blood-disorder-treatments

Orphan blood disease drugs to gain market

  • Japan
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Physicians treating rare blood disorders now have more drug treatments to choose from to treat patients. This in turn allows patients to avoid demanding... Read more

novartis-recalls-triaminic-syrups-theraflu-warming-relief-syrups-jack-jill-brand-pediatric-syrups-and-buckley-s-complete-liquids

Novartis recalls OTC drugs for bottle closure defect

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Novartis Pharma is voluntarily recalling certain lots of Triaminic Syrups, Theraflu Warming Relief Syrups, Jack & Jill brand pediatric syrups and Buckley's... Read more

good-news-for-metastatic-colorectal-cancer-mcrc-patients-sanofi-and-regeneron-pharmaceuticals-zaltrap-25mgml-concentrate-gets-marketing-authorization-in-the-european-union

Sanofi, Regeneron cancer drug Zaltrap gets EU nod

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltrap 25mg/ml concentrate in the European Union.... Read more

mous-signed-at-bangalore-india-bio-2013-on-day-1-karnataka-biotechnology-and-information-technology-services-kbits-with-scottish-development-international-sdi-and-kbits-with-georgia-department-of-economic

India, Scotland join hands at Bangalore India Bio

  • India
  • |
  • News
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Bangalore: Bangalore India Bio 2013, which is India's premier biotech forum renowned for calibrating the pulse of the biotechnology industry, started in the biotech... Read more

cytomegalovirus-treatments-to-improve

Cytomegalovirus treatments to improve

  • Europe
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generally asymptomatic in healthy children and adults,... Read more

2012-was-a-bad-year-for-astrazeneca-revenue-declined-15-percent-to-usd27-973-mn

Have a look at AstraZeneca's development pipeline

  • Europe
  • |
  • Company Results
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AstraZeneca (AZ) revealed that during its fourth quarter and the full year of 2012, its revenue declined 15 percent at constant exchange rates (CER) to... Read more

gbi-research-worldwide-statins-market-will-drop-usd19

Generics will lead to $7 bn loss for statins market

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GBI Research has highlighted that the introduction of generic statins has kick started a decline in the global statins market and this is expected to... Read more

dezima-mitsubishi-license

Dezima in-licenses CETP inhibitor from Mitsubishi

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Dezima Pharma, a biotechnology company developing innovative drugs in the field of dyslipidemia, has in-licensed a cholesteryl ester transfer protein... Read more

good-news-for-allergic-rhinitis-patients-meda-s-dymista-gets-medical-approval-in-europe

Meda allergic rhinitis drug Dymista gets EU nod

  • Europe
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Meda's Dymista received medical approval in Europe for the treatment of seasonal and perennial allergic rhinitis, via the decentralized registration procedure.... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X